Perspectives on remote patient monitoring with self-operated OCT for management of neovascular age-related macular degeneration

References

• Toth CA, Decroos FC, Ying GS, et al. Identification of Fluid on Optical Coherence Tomography by Treating Ophthalmologists Versus a Reading Center in the Comparison of Age-Related Macular Degeneration Treatments Trials. Retina. 2015;35(7):1303–1314.
   PubMed Web of Science ®Google Scholar
• American Academy of Ophthalmology. Age-related macular degeneration preferred practice patterns. Preferred practice patterns 2015; https://www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp-2015. 2019 April 25, 2019.
   Google Scholar
• Schmidt-Erfurth U, Chong V, Loewenstein A, et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014;98(9):1144–1167.
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, Williams M, Group AMDG. The Royal College of Ophthalmologists Guidelines on AMD: executive Summary. Eye (Lond). 2013;27(12):1429–1431.
   PubMed Web of Science ®Google Scholar
• The National Institute for Health and Care Excellence. Age-related macular degeneration. NICE guideline. 2018; https://www.nice.org.uk/guidance/NG82. 2020 April 13, 2020.
   Google Scholar
• Chakravarthy U, Pillai N, Syntosi A, et al. Association between visual acuity, lesion activity markers and retreatment decisions in neovascular age-related macular degeneration. Eye (Lond). 2020;34(12):2249–2256.
   PubMed Web of Science ®Google Scholar
• Thier A, Holmberg C. The patients’ view: age-related macular degeneration and its effects - a meta-synthesis. Disabil Rehabil. 2020;1–11. DOI:https://doi.org/10.1080/09638288.2020.1775901
   Google Scholar
• Boyle J, Vukicevic M, Koklanis K, et al. Experiences of patients undergoing repeated intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration. Psychol Health Med. 2018;23(2):127–140.
   PubMed Web of Science ®Google Scholar
• Prenner JL, Halperin LS, Rycroft C, et al. Disease Burden in the Treatment of Age-Related Macular Degeneration: findings From a Time-and-Motion Study. Am J Ophthalmol. 2015;160(4):725–731 e721. .
   PubMed Web of Science ®Google Scholar
• Gohil R, Crosby-Nwaobi R, Forbes A, et al. Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration. PLoS One. 2015;10(6):e0129361.
   PubMed Web of Science ®Google Scholar
• NHS Digital. Hospital Outpatient Activity 2019–20. digital.nhs.uk/data-and-information/publications/statistical/hospital-outpatient-activity/2019-20. 2020 December 21.
   Google Scholar
• Okada M, Mitchell P, Finger RP, et al. Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: a Mixed-Methods Systematic Review. Ophthalmology. 2020;128(2):234-247.
   Google Scholar
• Keenan TDL, Chakravarthy U, Loewenstein A, et al. Automated quantitative assessment of retinal fluid volumes as important biomarkers in neovascular age-related macular degeneration. Am J Ophthalmol. 2020;224:267-281.
   Web of Science ®Google Scholar
• Garcia-Quintanilla L, Luaces-Rodriguez A, Gil-Martinez M, et al. Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration. Pharmaceutics. 2019;11:8.
   Web of Science ®Google Scholar
• Li E, Donati S, Lindsley KB, et al. Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2020;5:CD012208.
   PubMedGoogle Scholar
• Okada M, Kandasamy R, Chong EW, et al. The Treat-and-Extend Injection Regimen Versus Alternate Dosing Strategies in Age-related Macular Degeneration: a Systematic Review and Meta-analysis. Am J Ophthalmol. 2018;192:184–197.
   PubMed Web of Science ®Google Scholar
• Lalwani GA, Rosenfeld PJ, Fung AE, et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol. 2009;148(1):43–58. e41.
   PubMed Web of Science ®Google Scholar
• Spaide R. Ranibizumab according to need: a treatment for age-related macular degeneration. Am J Ophthalmol. 2007;143(4):679–680.
   PubMed Web of Science ®Google Scholar
• Comparison of Age-related Macular Degeneration Treatments Trials Research Group, Martin DF, Maguire MG, Fine SL, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012;119(7):1388–1398.
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, Harding SP, Rogers CA, et al. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet. 2013;382(9900):1258–1267.
   PubMed Web of Science ®Google Scholar
• Rufai SR, Almuhtaseb H, Paul RM, et al. A systematic review to assess the ‘treat-and-extend’ dosing regimen for neovascular age-related macular degeneration using ranibizumab. Eye (Lond). 2017;31(9):1337–1344.
   PubMed Web of Science ®Google Scholar
• Bontzos G, Bagheri S, Ioanidi L, et al. Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: a Prospective Spectral-Domain OCT Study. Ophthalmol Retina. 2020;4(12):1138–1145.
   PubMedGoogle Scholar
• Mehta H, Tufail A, Daien V, et al. Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors. Prog Retin Eye Res. 2018;65:127–146.
   PubMed Web of Science ®Google Scholar
• Ho AC, Kleinman DM, Lum FC, et al. Baseline Visual Acuity at Wet AMD Diagnosis Predicts Long-Term Vision Outcomes: an Analysis of the IRIS Registry. Ophthalmic Surg Lasers Imaging Retina. 2020;51(11):633–639.
   PubMed Web of Science ®Google Scholar
• Khanani AM, Callanan D, Dreyer R, et al. End of Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration. Ophthalmol Retina. 2020;5(8):775-787.
   Google Scholar
• Moisseiev E, Novel Long-acting LA. Pharmacotherapy for Exudative Age Related Macular Degeneration. Curr Pharm Des. 2018;24(41):4860–4863.
   PubMed Web of Science ®Google Scholar
• Al-Khersan H, Hussain RM, Ciulla TA, et al. Innovative therapies for neovascular age-related macular degeneration. Expert Opin Pharmacother. 2019;20(15):1879–1891.
   PubMed Web of Science ®Google Scholar
• Kim JE 2020, Performance of a novel deep learning algorithm for automatic retinal fluid quantification in home OCT images. American Society of Retina Specialists Annual Scientific Meeting.
   Google Scholar
• Chakravarthy U, Havilio M, Syntosi A, et al. Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD. Eye (Lond). 2021. https://doi.org/10.1038/s41433-020-01354-4.
   Google Scholar
• Michl M, Fabianska M, Seeböck P, et al. Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy. Br J Ophthalmol. 2020; Oct 21. https://doi.org/10.1136/bjophthalmol-2020-317416.
   Google Scholar
• Mantel I, Mosinska A, Bergin C, et al. Automated Quantification of Pathological Fluids in Neovascular Age-Related Macular Degeneration, and Its Repeatability Using Deep Learning. Transl Vis Sci Technol. 2021 Apr;10:17. 1.
   PubMed Web of Science ®Google Scholar
• von der Burchard C, Moltmann M, Tode J, et al. Self-examination low-cost full-field OCT (SELFF-OCT) for patients with various macular diseases. Graefes Arch Clin Exp Ophthalmol. 2020;259(6):1503-1511.
   PubMed Web of Science ®Google Scholar
• Maloca P, Hasler PW, Barthelmes D, et al. Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring. Transl Vis Sci Technol. 2018;7(4):8.
   PubMed Web of Science ®Google Scholar
• Nahen K, Benyamini G, Loewenstein A. Evaluation of a Self-Imaging SD-OCT System for Remote Monitoring of Patients with Neovascular Age Related Macular Degeneration. Klin Monbl Augenheilkd. 2020;237(12):1410–1418.
   PubMed Web of Science ®Google Scholar
• Keenan TDL, Goldstein M, Goldenberg D, et al., Prospective longitudinal pilot study: daily self-imaging with patient-operated home OCT in neovascular age-related macular degeneration. Ophthalmol Sci. 2021 (in press). 1. 100034.
   Google Scholar
• Ho AC, Heier JS, Holekamp NM, et al., Real-World performance of a self-operated home monitoring system for early detection of neovascular age-related macular degeneration. J Clin Med. 10(7): 1355. 2021.
   PubMed Web of Science ®Google Scholar